Skip to main content

EDITORIAL article

Front. Bioeng. Biotechnol., 04 April 2023
Sec. Biomaterials
Volume 11 - 2023 | https://doi.org/10.3389/fbioe.2023.1193168

Editorial: Bio and nanomaterials in tissue engineering and regenerative medicine (BioNTERM)

  • 1Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada
  • 2Department of Chemical & Materials Engineering, University of Alberta, Edmonton, AB, Canada
  • 3Department of Ophthalmology and Institute of Biomedical Engineering, Montreal University, Montreal, QC, Canada
  • 4Department of Mining, Metallurgical and Materials Engineering, Laval University, Quebec City, QC, Canada

For many, 2020 will be remembered as the year our lives were put on hold. For scientists, the COVID-19 pandemic took away scientific conferences and student/faculty mobility programs, which are essential for diversifying ideas and establishing new collaborations. The field of biomaterials was no exception. With many groups and their students not being able to interact with peers, the editors of this unique Frontiers Research Topic, in collaboration with a talented team of trainees in Canada, decided to take matters into their own hands. This is how the virtual conference and workshop series on Bio and nanomaterials in tissue engineering and regenerative medicine (BioNTERM) was born. BioNTERM was first virtually held on March 2021 with plenary lectures and workshops. BioNTERM covered different but closely interrelated topics of bio and nanomaterials in tissue engineering ranging from Science Communication to 3D-bioprinting. With over 600 attendees from +20 countries, this free event was a tremendous success. The articles presented in this special Frontiers issue represent the diaspora of topics BioNTERM touched on.

The Research Topic of articles includes studies on translational materials such as a peptide-based material for on-the-spot cornea repair (Juarez et al.) and the impact of electron-bean irradiation on pre-made collagen-based corneal implants (Simpson et al.). Fundamental research on the effects of processing techniques for obtaining silk-fibroin (Wang Y et al.) and using plant viral nanoparticles as an additive for gelatin methacryloyl hydrogels for building complex 3D structures (González-Gamboa et al.). This Research Topic includes two mini-reviews that revise recent developments on using peptides to prepare biomaterials (Ross et al.) and some of the most common methodologies used in bioengineering lung scaffolds (Shakir et al.). Finally, a comprehensive review of the use of mRNA-containing biomaterials for bone repair is also part of this Research Topic (Wang J et al.).

The editors of this Research Topic would like to thank the scientists who contributed their work to this volume. While we are not still over the COVID-19 pandemic, we are convinced our scientific community has become stronger, more resilient, and highly connected. The lessons learned on using digital technologies to connect, network, and share scientific knowledge during the pandemic are crucial to building a more inclusive scientific and societal ecosystem for future generations.

Author contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: biomaterials, clinical translation, innovation, nanomateials, bioprinting

Citation: Alarcon EI, Uludag H, Griffith M and Mantovani D (2023) Editorial: Bio and nanomaterials in tissue engineering and regenerative medicine (BioNTERM). Front. Bioeng. Biotechnol. 11:1193168. doi: 10.3389/fbioe.2023.1193168

Received: 24 March 2023; Accepted: 30 March 2023;
Published: 04 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Alarcon, Uludag, Griffith and Mantovani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Emilio Isaac Alarcon, ealarcon@uottawa.ca

Download